Fremont conversion and the humanoid deployment year — when Tesla phases out the Model S to bet on Optimus and Boston Dynamics tens-of-thousands at Hyundai

Tesla converting Fremont to humanoid production in Q2 2026, phasing out Model S and Model X assembly to make way for Optimus capacity at 1M units per year, is the most aggressive humanoid bet Tesla has made. Boston Dynamics deploying Atlas at tens-of-thousands scale at Hyundai with $100B IPO valuation discussions is the deployment-validated competitor story. The 2026-2027 humanoid market has its three-vendor shape: Tesla on consumer, Boston Dynamics on factory, Figure as the third position.

The Tesla Fremont conversion is the substantive operational news. Phasing out Model S and Model X — the legacy premium-sedan products that have been at Fremont since 2012 — to make way for Optimus production is the inflection moment Tesla's product strategy crosses from automotive incumbency into humanoid-robotics commitment. The 1M units per year target at Fremont is consistent with what auto-industry analysts have estimated as the practical maximum throughput Fremont can support with humanoid product lines, and it puts Tesla's stated humanoid ambition at the scale required to be a major market participant.

The Optimus V3 specifications matter as the technically-credible piece. 37 joints (up from 28 in V2) is in the same envelope as Figure 03 and approaches Boston Dynamics Atlas's 56 DOF. The 1.2 m/s walk speed and 15° slope stability are within the range competitive deployments need for factory and consumer work. The reveal in late July or August plus Fremont production capacity coming online creates the 2027 competitive window where humanoid-deployment evidence settles which players capture which segments. Musk declining to set a 2026 unit-shipment target is the candid-information piece — production ramp from V3 reveal to meaningful volume historically takes 12-18 months even for Tesla's well-tuned manufacturing operation.

The Boston Dynamics deployment-validation story is the parallel competitive milestone. Atlas deploying at tens-of-thousands scale across Hyundai manufacturing facilities with internal IPO discussions reportedly using a $100B valuation comparison is the structural shift from demo-phase to commercial-production-phase. After 15+ years of public Atlas demonstrations, the company had never publicly committed to large-scale factory deployment numbers; the Hyundai parent-company relationship now produces that commitment at scale. The deployment is on real factory floors, doing real manufacturing work, against measurable productivity targets.

The Figure 03 third position completes the three-vendor market structure. Figure has been live at BMW Spartanburg for several quarters and reports 40+ units running production-grade tasks at $25/robot-hour. Figure 03's head-to-head capability ranking against Tesla Optimus V2 (78.9 vs 45.1 in May 2026 evaluations) is the third-party benchmark. Figure 03 targets consumer home use late 2026, which means by end-of-year the humanoid market has Boston Dynamics on factory deployments at Hyundai, Figure on both factory (BMW) and consumer (late 2026 launch), Tesla on the consumer-and-factory ramp from V3 reveal.

The consumer-humanoid question is the strategic differentiator. 1X NEO has 10,000 home pre-orders at $499/month subscription or $20K outright, with deliveries expected by end of 2026. If 1X hits the delivery window, the consumer humanoid market validates ahead of Tesla's V3 production ramp — which puts Tesla in a competitive position with both Figure (factory plus consumer) and 1X (consumer-first) ahead of its own production ramp. The factory-first vs consumer-first strategic question is what determines whether Tesla's Fremont conversion bet works: if the consumer market validates and Tesla converts Fremont to consumer-grade Optimus production on schedule, the bet pays. If 1X captures the consumer market or the market doesn't validate at all, Fremont is a stranded asset.

The market sizing supports multi-winner outcomes. Humanoid robotics market valued at $2.03B in 2024 is projected to exceed $13B by 2029. Boston Dynamics with Hyundai and Google DeepMind anchor customers, Figure with BMW and expanding, 1X with consumer pre-order pipeline, Tesla with Fremont production capacity coming online in 2027, plus the Chinese competitors (Unitree, Xpeng, Agility's domestic challengers) all have credible paths to multi-billion-dollar businesses in a market that grows 7x by 2029. The race is not winner-take-all; it's about which segment each competitor captures and at what margin.

The $100B valuation framing for Boston Dynamics is the strategic positioning piece that matters beyond the company itself. Comparing Boston Dynamics' commercial position against a $100B benchmark places the company in the same valuation tier as the largest pure-play AI labs (Anthropic at $900B, OpenAI at significantly higher) and signals that humanoid robotics is now considered a category-defining-incumbent business rather than a specialty-robotics market. Whether Boston Dynamics actually IPOs at $100B or substantially below is a function of how the broader market scales, but the framing changes how venture capital and public-market investors price the entire humanoid category.

The line: humanoid robotics demos used to be a YouTube category. In 2026 it is a multi-vendor production-deployment market with $100B valuation comparisons, and the 2027 numbers determine winners.

Standard Bots — Tesla robot price 2026 Optimus → · The Register — Boston Dynamics Atlas production launch → · New Market Pitch — Figure 03 vs Tesla Optimus Tracker 2026 →